Intracranial Stimulation Mapping for Epilepsy
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to create detailed brain maps to better understand how brain regions communicate in people with partial epilepsy. It focuses on using a treatment called Intracranial Stimulation Mapping, which involves electrical stimulation of the brain, to discover how different brain parts connect. The study seeks adults already undergoing special brain monitoring (intracranial EEG) to assist in planning their epilepsy surgery. Participants should be willing to follow all study procedures and be available for the entire study duration. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research that could enhance epilepsy treatment strategies.
Do I need to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. Please consult with the study team for guidance.
What prior data suggests that this intracranial stimulation mapping is safe for epilepsy patients?
Research has shown that brain mapping using intracranial stimulation is generally well-tolerated in people with epilepsy. This technique uses electrical stimulation to identify important brain areas before surgery.
One study found that this method helps locate where seizures begin in the brain by monitoring brain activity with special equipment. Another study confirmed the safety of this approach, noting its use in patients with various brain conditions, such as arteriovenous malformations (a type of blood vessel issue in the brain).
Overall, these findings suggest that intracranial stimulation mapping is safe when performed in controlled settings. However, like any procedure, it carries risks and should be conducted under careful medical supervision.12345Why are researchers excited about this trial?
Intracranial Stimulation Mapping is unique because it offers a new way to pinpoint and understand the functional areas of the brain responsible for triggering epileptic seizures. Unlike traditional treatments like medication or resective surgery, which often aim to prevent or remove the source of seizures, this technique focuses on accurately mapping brain activity. Researchers are excited about this method because it could lead to more precise, personalized treatment plans, potentially improving outcomes for patients with epilepsy by minimizing unnecessary removal of healthy brain tissue.
What evidence suggests that Intracranial Stimulation Mapping is effective for epilepsy?
Research shows that Intracranial Stimulation Mapping (IESM), the method under study in this trial, can help identify where seizures begin in the brain. One study found that using this method reduced seizures by 50% or more in 80% of patients who experienced seizures during the procedure. This technique involves closely monitoring the brain with special equipment, making it easier to locate the exact areas involved in seizures. Studies also indicate that IESM can reveal different levels of brain activity, enhancing understanding of brain reactions. Overall, this approach holds promise for better managing epilepsy by accurately identifying the key brain regions involved in seizures.12367
Who Is on the Research Team?
Alexander Herman, MD
Principal Investigator
UMN
Are You a Good Fit for This Trial?
This trial is for adults over 18 with epilepsy who are already getting intracranial EEG monitoring at the University of Minnesota/MINCEP program. They must understand the study, agree to all procedures, and be available throughout. Pregnant individuals or those unable to make independent decisions due to cognitive impairments are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo intracranial stimulation mapping to generate brain maps for localizing cerebral functions and inter-regional information flow
Follow-up
Participants are monitored for safety and effectiveness after stimulation sessions
What Are the Treatments Tested in This Trial?
Interventions
- Intracranial Stimulation Mapping
Intracranial Stimulation Mapping is already approved in United States, European Union, Canada for the following indications:
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Minnesota
Lead Sponsor